Gaba Therapeutics
Newport Beach
About Gaba Therapeutics
GABA Therapeutics is developing GRX-917, an anxiety medication. The drug’s dual mechanism of action may also benefit a broad range of neuropsychiatric and neurological disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.5M
- Last round: Undisclosed (Mar 2024)
- Website: gabarx.com
- Phone: (855) 277-3477
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/gaba-therapeutics-114130 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.